Updated results from a phase 3 trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naive patients with advanced melanoma (MEL) (CheckMate 067) Meeting Abstract
| Authors: | Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; Dummer, R.; Hill, A.; Haanen, J.; Maio, M.; McArthur, G.; Walker, D.; Jiang, J.; Horak, C.; Larkin, J.; Hodi, S. |
| Abstract Title: | Updated results from a phase 3 trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naive patients with advanced melanoma (MEL) (CheckMate 067) |
| Meeting Title: | COSA's 43rd Annual Scientific Meeting |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 12 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2016 Nov 15-17 |
| Meeting Location: | Queensland, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2016-11-01 |
| Start Page: | 127 |
| End Page: | 128 |
| Language: | English |
| ACCESSION: | WOS:000387769900193 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.12646 |
| Notes: | Meeting Abstract: 244 -- Source: Wos |
